Joan's Legacy: Uniting Against Lung Cancer
27 Union Square West, Suite 304, New York, NY 10003 • ph: 212.627.5500 • fax: 212.627.7594
 
 

 

Dennis A. Wigle, B.Sc., M.Sc., M.D., Ph.D., Mayo Clinic: A Single Nucleotide Polymorphism (SNP) Association Study to Investigate the Genetic Basis of Bronchioalveolar Carcinoma

This grant is being fully funded by the Thomas G. Labrecque Foundation, through the Joan’s Legacy Grant Program.

Peripheral lung adenocarcinoma, and bronchioalveolar carcinoma (BAC) in particular, continues to account for the majority of lung cancers in young (<55), non-smoking, women. BAC patients constitute about 5% of the total lung cancer patients in the U.S. The incidence of these cancers has risen exponentially in the United States over the past four decades, at a time when the incidence of other non-small cell lung cancers has either levelled off or declined. Lung cancer overall is now responsible for more cancer-related deaths than any other cancer, killing more women in the United States each year than breast and ovarian cancers combined.
Very little is known about the underlying biology or genetic basis of BAC. The Mayo Clinic has a large tumor bank of surgically resected lung cancer specimens that also contains blood samples from individual patients. The associated database contains detailed information regarding clinical follow up. Among this group of over 5,000 patients, approximately 300 patients have a diagnosis of BAC, and over 400 have adenocarcinoma with BAC features. We will use this rich clinical resource to investigate genetic polymorphisms or “SNPs” in blood samples from patients who have developed BAC. The recent publication of the International HapMap Consortium dataset has catalogued over one million single nucleotide polymorphisms or “SNPs” within the human genome. It is thought that this genetic variation amongst individuals accounts for much of the individual difference in disease susceptibility for cancer. In this project, we will use high-density SNP arrays to investigate over 550,000 individual SNPs in patients with BAC and matched controls. This whole genome survey will analyse the majority of validated SNPs within the human genome in an attempt to find genetic abnormalities associated with the development of BAC. SNP associations with disease susceptibility from this project will provide lead data toward the project goal of defining the underlying genetic basis for the development of BAC.

 
 
Joan's Legacy is a 501(c)(3) tax-exempt organization.